EXCESSIVE NAKED MEGAKARYOCYTE NUCLEI IN MYELODYSPLASTIC SYNDROME MIMICKING IDIOPATHIC THROMBOCYTOPENIC PURPURA: A Complicated Pre- and Post-transplantation Course

REFERENCES

• Menke DM, Colon-Otero G, Cockerill KJ, Jenkins RB, Noel P, Pierre RV. Refractory thrombocytopenia: a myelodysplastic syndrome that may mimic immune thrombocytopenic purpura. Am J Clin Pathol. 1992;98:502–510.
   PubMed Web of Science ®Google Scholar
• Rosati S, Mick R, Xu F, Refractory cytopenia with multilineage dysplasia: further characterization of an ‘Unclassifiable’ myelodysplastic syndrome. Leukemia. 1996;10:20–26.
   PubMed Web of Science ®Google Scholar
• Brunning RD. Morphologic classifications of myelodysplastic syndromes: French-American-British (FAB) and World Health Organization (WHO). In: Greenberg PL, ( ed.), Myelodysplastic Syndromes: Clinical and Biological Advances. Cambridge, UK: Cambridge University Press; 2006:95–128.
   Google Scholar
• Hasle H. Myelodysplastic Syndrome. In: Childhood Leukemias, 2nd. Pui C-H, ( Ed.), Cambridge University Press; Cambridge, UK: 2006548–570.
   Google Scholar
• Yetgin S, Olcay L, Özsoylu Ş, Hiçsönmez G, Gürgey A, Tuncer AM. Retrospective analysis of 78 children with chronic idiopathic thrombocytopenic purpura: follow-up from 1976 to 1996. Pediatr Hematol Oncol. 1997;14:399–412.
   PubMed Web of Science ®Google Scholar
• Olcay L, Yetgin S, Okur H, Erdemli E. Rapid cell senescence and apoptosis in lymphocytes and granulocytes and absence of GM-CSF receptor in congenital dysgranulopoietic neutropenia. Leuk Res. 2007;32:235–242.
   Google Scholar
• Kerr JFR. Definition of apoptosis and overview of its incidence. In: Lavin M, Watters D, eds. Cell Death: The Cellular & Molecular Biology of Apoptosis. Brisbane: Harwood Academic; 1993:1–19.
   Google Scholar
• Thiele J, Lorenzen J, Manich B, Kvasnicka HM, Zirbes TK, Fischer R. Apoptosis (programmed cell death) in idiopathic (primary) osteo-/myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis. Acta Haematol. 1997;97:137–143.
   PubMed Web of Science ®Google Scholar
• Martin SJ, Reutelingsperger CPM, Green DR. Annexin V: a specific probe for apoptotic cells. In: Cotter TG, Martin SJ, ( eds. Techniques in Apoptosis: A User's Guide. Portland Press; London: 1996;105–119.
   Google Scholar
• Hicsonmez G, Cetin M, Yenicesu I, Evaluation of children with myelodysplastic syndrome:importance of extramedullary disease as a presenting symptom. Leuk Lymphoma. 2001;42:665–674.
   PubMed Web of Science ®Google Scholar
• Olcay L, Yetgin S, Okur H, Erekul S, Tuncer M. Dysplastic changes in idiopathic thrombocytopenic purpura and the effect of corticosteroids to increase dysplasia and cause hyperdiploid macropolycytes. Am J Hematol. 2000;65:99–104.
   PubMed Web of Science ®Google Scholar
• Houwerzijl EJ, Blom NR, van der Want JJL, Increased peripheral platelet destruction and caspase-3-independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients. Blood. 2005;105:3472–3479.
   PubMed Web of Science ®Google Scholar
• Hu T, Shi XD, Feng YL, Comperative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome. Zhonghua Er Ke Za Zhi. 2005;43:183–187.
   Google Scholar
• Raza A, Gezer S, Mundle S, Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995;86:268–726.
   PubMed Web of Science ®Google Scholar
• Houwerzijl EJ, Blom NR, van der Want JJL, Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood. 2004;103:500–506.
   PubMed Web of Science ®Google Scholar
• Hofmann W-K, Kalina U, Koschmieder S, Seipelt G, Hoelzer D, Ottmann OG. Defective megakaryocytic development in myelodysplastic syndromes. Leuk Lymphoma. 2000;38:13–19.
   PubMed Web of Science ®Google Scholar
• Howard MR, Kesteven PJL. Sea blue histiocytosis: a common abnormality of the bone marrow in myelodysplastic syndromes. J Clin Pathol. 1993;46:1030–1032.
   PubMed Web of Science ®Google Scholar
• Aslan D, Yetgin S. Megakaryocyte emperipolesis in a child with chronic neutropenia: an unusual coexistence. Turk J Pediatr. 2001;43:255–256.
   Google Scholar
• Bauer S, Khan A, Klein A, Starasoler L. Naked megakaryocyte nuclei as an indicator of human immunodeficiency virus infection. Arch Pathol Lab Med. 1992;116:1025–1029.
   PubMed Web of Science ®Google Scholar
• Gordon S, Lee S. Naked megakaryocyte nuclei in bone marrows of patients with acquired immunodeficiency syndrome: a somewhat specific finding. Modern Pathol. 1994;7:166–168.
   PubMed Web of Science ®Google Scholar
• Li X, Pu Q. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes. Leuk Lymphoma. 2005;46:387–391.
   PubMed Web of Science ®Google Scholar
• Olsson B, Andersson P-O, Jacobsson S, Carlsson L, Wadenvik H. Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura. Thromb Haemost. 2005;93:139–144.
   PubMed Web of Science ®Google Scholar
• Hamada K, Takahashi I, Matsuoka M, Apoptosis of peripheral leukocytes in patients with myelodysplastic syndromes. Rinsho Ketsueki. 1998;39:1079–1084.
   Google Scholar
• Fedorko ME, Lichtman MA. Megakaryocyte structure, maturation and ecology. In: Colman RW, ed. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: JBLippincott, 1982:210–224.
   Google Scholar
• Olney HJ, Le Beau MM. Cytogenetic abnormalities in myelodysplastic syndromes. In: Greenberg PL, ed. Myelodysplastic Syndromes: Clinical and Biological Advances. Cambridge, UK: Cambridge University Press; 2006:95–128.
   Google Scholar
• Hebbar M, Kaplan C, Caulier MT, Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy. Br J Haematol. 1996;94:112–115.
   Google Scholar